The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...
The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices ...
In a September 25, 2024 editorial, The Wall Street Journal notes that if the FTC is successful, it will result in higher drug costs for American consumers. The Congressional Budget Office (CBO ...
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...
House Oversight Committee Republicans argued that the government’s consumer protection chief violated the Federal Trade ...
How do we know that Lina Khan has done an excellent job as FTC chair? Because billionaires and business leaders want her gone ...
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
The Federal Trade Commission (FTC) on Nov. 6 issued an order approving the Horseracing Integrity and Safety Authority's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback